Results 241 to 250 of about 47,769 (294)

Antiseizure medication choice in diffuse glioma: A single-center population-based experience. [PDF]

Epilepsia Open
Ollila L, Roivainen R.
europepmc   +1 more source

Ten‐Year Outcomes of Anticholinergic Use Among Older Adults With Intellectual Disability: Findings From the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS‐TILDA)

Journal of Intellectual Disability Research, EarlyView.
ABSTRACT Background People with intellectual disability are frequently exposed to medication with anticholinergic activity. In the general population, the long‐term exposure to anticholinergics has been associated with declines in both physical and cognitive function.
Lamya Al Shuhaimi, Ian D. Maidment, Martin C. Henman, Phyo K. Myint, Juliette O'Connell, Caitríona Ryan, Philip McCallion, Mary McCarron, Maire O'Dwyer   +8 more
wiley   +1 more source

Dreaming in patients with epilepsy: a cross‐sectional cohort study

Journal of Sleep Research, EarlyView.
Dream recall frequency in patients with epilepsy is modulated by determinants shared with healthy subjects (age, nocturnal awakenings, role of the parieto‐occipital region) and by epilepsy‐related factors (seizure frequency, epileptic focus location).
Maïlis Charpentier‐Hélary, Aurélien de la Chapelle, Maxime Linard, Nathalie André‐Obadia, Sébastien Boulogne, Hélène Catenoix, Julien Jung, Sylvain Rheims, Katharina Schiller, Birgit Frauscher, Perrine Ruby, Laure Peter‐Derex   +11 more
wiley   +1 more source

Environmental implications of Si₂BN nanoflakes in pharmaceutical pollutant detection and removal: insights from first-principle calculations. [PDF]

Sci Rep
Elbendary N, Abdelsalam H, Ibrahim MA, Tawfik W, Khalil MMH.   +4 more
europepmc   +1 more source

The Future of Parasomnias

Journal of Sleep Research, EarlyView.
ABSTRACT Parasomnias are abnormal behaviours or mental experiences during sleep or the sleep–wake transition. As disorders of arousal (DOA) or REM sleep behaviour disorder (RBD) can be difficult to capture in the sleep laboratory and may need to be diagnosed in large communities, new home diagnostic devices are being developed, including actigraphy ...
Claudia Picard‐Deland, Matteo Cesari, Ambra Stefani, Jean‐Baptiste Maranci, Birgit Hogl, Isabelle Arnulf   +5 more
wiley   +1 more source

Enhanced Removal of Common Wastewater-Derived Trace Organic Contaminants in Vertical-Flow Constructed Wetlands Amended with Fe(III)-EDTA. [PDF]

ACS Environ Au
Anderson CM, Mushtaq A, Leckie M, Scholes RC.   +3 more
europepmc   +1 more source

Co‐Occurrence of High‐Frequency Oscillations and Interictal Focal Paroxysmal Fast Activity During Scalp EEG: A Comparison With Single Spikes

Neurology and Clinical Neuroscience, EarlyView.
ABSTRACT Interictal focal paroxysmal fast activity is a pattern seen in scalp electroencephalography recordings of patients with epilepsy, but its clinical relevance remains unclear. High‐frequency oscillations, considered a surrogate marker of epileptogenicity, are being studied in relation to scalp electroencephalography. To explore the importance of
Tatsuya Sato, Jumpei Togawa, Katsuya Kobayashi, Kiyohide Usami, Akihiro Shimotake, Mayumi Otani, Maya Tojima, Masao Matsuhashi, Ryosuke Takahashi, Akio Ikeda   +9 more
wiley   +1 more source

An Evaluation of Cation-Chloride Cotransporters NKCC1 and KCC2 in Carbamazepine-Resistant Rats. [PDF]

Int J Mol Sci
Zavala-Tecuapetla C, Orozco-Suárez S, Vega-García A, Manjarrez-Marmolejo J.   +3 more
europepmc   +1 more source

Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen. [PDF]

Headache
Muñoz-Vendrell A, Valín-Villanueva P, Tena-Cucala R, Campoy S, Martínez-Yélamos S, Huerta-Villanueva M.   +5 more
europepmc   +1 more source

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

Clinical Pharmacology &Therapeutics, Volume 118, Issue 3, Page 561-566, September 2025.
There is increasing attention on the clinical utility and value of pharmacogenetic (PGx) testing to individualize medication management. Most clinical practice guidelines from medical professional societies do not recommend routine PGx testing, with a few key exceptions.
James M. Stevenson, D. Max Smith, Sony Tuteja, Jai N. Patel, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +4 more
wiley   +1 more source